| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.83B | 25.23B | 19.95B | 19.82B | 19.64B | 19.06B |
| Gross Profit | 20.32B | 21.83B | 18.80B | 19.58B | 19.42B | 18.81B |
| EBITDA | 17.35B | 4.78B | 4.62B | 3.26B | 2.53B | 3.57B |
| Net Income | 2.47B | 2.80B | 2.50B | 1.72B | 1.28B | 2.04B |
Balance Sheet | ||||||
| Total Assets | 1.70T | 1.70T | 1.68T | 1.63T | 1.61T | 1.70T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 146.36B | 127.11B | 85.98B | 104.37B | 237.74B |
| Total Debt | 141.85B | 104.44B | 88.10B | 70.20B | 52.10B | 138.00B |
| Total Liabilities | 1.62T | 1.62T | 1.60T | 1.55T | 1.53T | 1.62T |
| Stockholders Equity | 78.15B | 80.80B | 74.98B | 77.65B | 73.11B | 76.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.92B | 0.00 | 11.56B | -139.63B | -4.52B |
| Operating Cash Flow | 0.00 | 7.70B | 0.00 | 1.60B | -139.40B | -4.19B |
| Investing Cash Flow | 0.00 | -9.43B | 846.00M | -19.40B | 6.62B | 10.63B |
| Financing Cash Flow | 0.00 | 18.02B | -649.00M | -592.00M | -589.00M | -592.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥26.77B | 9.65 | ― | 3.50% | 1.03% | 12.15% | |
69 Neutral | ¥13.84B | 8.73 | ― | 3.30% | 20.18% | 20.57% | |
68 Neutral | ¥12.41B | 7.38 | ― | 3.74% | 15.32% | 26.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥28.96B | 14.07 | ― | 2.59% | 17.44% | 9.26% | |
59 Neutral | ¥17.13B | 14.62 | ― | 3.37% | 6.15% | -0.87% | |
52 Neutral | ¥11.96B | 16.25 | ― | 1.89% | 17.42% | ― |